SJ Medical
SJ Medical
Uruguay has emerged as a regional leader in South American healthcare, characterized by a sophisticated medical infrastructure and a high demand for innovative cardiovascular treatments. As a premier Bioresorbable Vascular Scaffolds (BVS) Manufacturer & Exporter, we recognize the unique needs of the Uruguayan market, where the National Health Insurance (FONASA) and private mutualists seek cost-effective yet cutting-edge solutions for coronary artery disease.
In Montevideo and across cities like Salto and Paysandú, the shift from traditional Drug-Eluting Stents (DES) to Bioresorbable Scaffolds represents a leap toward "vessel restoration therapy." Unlike permanent metal stents, our Sirolimus-eluting bioresorbable coronary stents provide temporary support to the vessel wall before being fully absorbed by the body, leaving behind a natural, functional artery.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Our offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, we have obtained multiple patents and international certifications.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
Our technical team, comprising industry veterans with decades of experience, ensures that every bioresorbable scaffold exported to Uruguay meets rigorous clinical safety profiles. We utilize precision laser welding, balloon forming equipment, and Sirolimus coating technologies that are at the forefront of global MedTech.
The Uruguayan cardiology community is increasingly focusing on long-term clinical outcomes. The trend is moving away from permanent implants that can cause late-stage thrombosis or chronic inflammation. Bioresorbable Vascular Scaffolds (BVS) address these concerns by disappearing once the vessel has healed.
As an exporter, SJ Medical facilitates the adoption of these trends by providing comprehensive training and documentation that aligns with the Ministerio de Salud Pública (MSP) regulations in Uruguay.
Providing high-quality, durable scaffolds for the Administration of State Health Services (ASSE), ensuring that the general population has access to the same medical advancements as private clinics.
Supporting Uruguay's private healthcare providers with premium Sirolimus-Eluting Scaffolds that reduce the need for repeat revascularization, thus lowering long-term insurance costs.
Utilizing bioresorbable materials for congenital heart defect corrections where a permanent implant would hinder the natural growth of a child's vascular system.
SJ Medical strictly adheres to international quality standards. We have obtained CE certification, ISO 13485, and CFDA approval, alongside free sale certificates that empower our export operations to Uruguay and beyond.
Our footprint extends across Europe (Italy, Spain, Netherlands), Asia (India, Indonesia), and the Middle East (Turkey, Egypt). We are now actively strengthening our logistics and partnership network within the Mercosur trade bloc, with Uruguay serving as a strategic gateway for advanced vascular solutions in the Southern Cone.
